AAAAAA
Results: 1-25/35
Authors:
GRISWOLD MW
BRICELAND LL
STEIN DS
Citation: Mw. Griswold et al., IS AMPHOTERICIN-B TEST DOSING NEEDED, The Annals of pharmacotherapy, 32(4), 1998, pp. 475-477
Authors:
STEIN DS
HOOVER DR
GRAHAM NMH
CHU C
DETELS R
RIDDLER SA
PHAIR JP
SAAH AJ
Citation: Ds. Stein et al., THE EFFECT OF PROPHYLAXIS WITH DAPSONE ON DEVELOPMENT OF MYCOBACTERIUM-AVIUM-INTRACELLULARE DISEASE - AN ANALYSIS OF THE MULTICENTER AIDS COHORT STUDY, Infectious diseases in clinical practice, 7(8), 1998, pp. 395-399
Authors:
PRESTON SL
POSTELNICK M
PURDY BD
PETROLATI J
AASI H
STEIN DS
Citation: Sl. Preston et al., DRUG-INTERACTIONS IN HIV-POSITIVE PATIENTS INITIATED ON PROTEASE INHIBITOR THERAPY, AIDS, 12(2), 1998, pp. 228-230
Authors:
DRUSANO GL
STEIN DS
Citation: Gl. Drusano et Ds. Stein, MATHEMATICAL-MODELING OF THE INTERRELATIONSHIP OF CD4 LYMPHOCYTE COUNT AND VIRAL LOAD CHANGES INDUCED BY THE PROTEASE INHIBITOR INDINAVIR, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 358-361
Authors:
STEIN DS
Citation: Ds. Stein, HUMAN-PAPILLOMAVIRUS TYPE-16 AND RISK OF PREINVASIVE AND INVASIVE VULVAR CANCER - RESULTS FROM A SEROEPIDEMIOLOGICAL CASE-CONTROL STUDY, Obstetrics and gynecology, 91(4), 1998, pp. 638-638
Authors:
DRUSANO GL
BILELLO JA
STEIN DS
NESSLY M
MEIBOHM A
EMINI EA
DEUTSCH P
CONDRA J
CHODAKEWITZ J
HOLDER DJ
Citation: Gl. Drusano et al., FACTORS INFLUENCING THE EMERGENCE OF RESISTANCE TO INDINAVIR - ROLE OF VIROLOGICAL, IMMUNOLOGICAL, AND PHARMACOLOGICAL VARIABLES, The Journal of infectious diseases, 178(2), 1998, pp. 360-367
Authors:
STEIN DS
Citation: Ds. Stein, CYTOMEGALOVIRUS RETINITIS AFTER INITIATION OF HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY, Lancet, 350(9077), 1997, pp. 589-590
Authors:
LESAR TS
BRICELAND L
STEIN DS
Citation: Ts. Lesar et al., FACTORS RELATED TO ERRORS IN MEDICATION PRESCRIBING, JAMA, the journal of the American Medical Association, 277(4), 1997, pp. 312-317
Authors:
GRUBER SA
GALLICHIO M
ROSANO TG
KAPLAN SS
HUGHES SE
URBAUER DL
SINGH TP
LEMPERT N
CONTI DJ
STEIN DS
DRUSANO G
Citation: Sa. Gruber et al., COMPARATIVE PHARMACOKINETICS AND RENAL EFFECTS OF CYCLOSPORINE-A AND CYCLOSPORINE-G IN RENAL-ALLOGRAFT RECIPIENTS, Journal of clinical pharmacology, 37(7), 1997, pp. 575-586
Authors:
STEIN DS
DRUSANO GL
Citation: Ds. Stein et Gl. Drusano, MODELING OF THE CHANGE IN CD4 LYMPHOCYTE COUNTS IN PATIENTS BEFORE AND AFTER ADMINISTRATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE INHIBITOR INDINAVIR, Antimicrobial agents and chemotherapy, 41(2), 1997, pp. 449-453
Authors:
STEIN DS
LYLES RH
GRAHAM NMH
TASSONI CJ
MARGOLICK JB
PHAIR JP
RINALDO C
DETELS R
SAAH A
BILELLO J
Citation: Ds. Stein et al., PREDICTING CLINICAL PROGRESSION OR DEATH IN SUBJECTS WITH EARLY-STAGEHUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION - A COMPARATIVE-ANALYSISOF QUANTIFICATION OF HIV RNA, SOLUBLE TUMOR-NECROSIS-FACTOR TYPE-II RECEPTORS, NEOPTERIN, AND BETA(2)-MICROGLOBULIN, The Journal of infectious diseases, 176(5), 1997, pp. 1161-1167
Authors:
SCHOOLEY RT
CAMPBELL TB
KURITZKES DR
BLASCHKE T
STEIN DS
ROSANDICH ME
PHAIR J
POTTAGE JC
MESSARI F
COLLIER A
KAHN J
RAY G
CURTIS S
BAKHTIARI M
KESSLER H
COOMBS R
COREY L
VOLBERDING P
CALANDRA G
MASSARI F
Citation: Rt. Schooley et al., PHASE-1 STUDY OF COMBINATION THERAPY WITH L-697,661 AND ZIDOVUDINE, Journal of acquired immune deficiency syndromes and human retrovirology, 12(4), 1996, pp. 363-370
Authors:
STEIN DS
Citation: Ds. Stein, HERPES-VIRUS INFECTIONS AND THEIR INTERACTION WITH HIV DISEASE PROGRESSION, Bailliere's clinical infectious diseases, 3(1), 1996, pp. 1-13
Authors:
STEIN DS
GRAHAM NMH
Citation: Ds. Stein et Nmh. Graham, INTERACTION OF HERPES VIRUSES WITH HIV - CAN ANTIHERPES DRUGS PROLONGSURVIVAL AMONG AIDS PATIENTS, Reviews in medical virology, 6(3), 1996, pp. 163-172
Authors:
SPOLARICS Z
STEIN DS
GARCIA ZC
Citation: Z. Spolarics et al., ENDOTOXIN STIMULATES HYDROGEN-PEROXIDE DETOXIFYING ACTIVITY IN RAT HEPATIC ENDOTHELIAL-CELLS, Hepatology, 24(3), 1996, pp. 691-696
Authors:
STEIN DS
DUNN H
DRUSANO GL
Citation: Ds. Stein et al., ACUTE THROMBOCYTOPENIA SECONDARY TO THE ADMINISTRATION OF THE PEPTIDOMIMETIC HIV PROTEASE INHIBITOR MK-639 (L735524), AIDS, 10(6), 1996, pp. 678-680
Authors:
STEIN DS
FISH DG
BILELLO JA
PRESTON SL
MARTINEAU GL
DRUSANO GL
Citation: Ds. Stein et al., A 24-WEEK OPEN-LABEL PHASE I II EVALUATION OF THE HIV PROTEASE INHIBITOR MK-639 (INDINAVIR)/, AIDS, 10(5), 1996, pp. 485-492
Authors:
MEHLHAFF DL
STEIN DS
Citation: Dl. Mehlhaff et Ds. Stein, GOUT SECONDARY TO RITONAVIR AND DIDANOSINE, AIDS, 10(14), 1996, pp. 1744-1744
Authors:
SARAVOLATZ LD
WINSLOW DL
COLLINS G
HODGES JS
PETTINELLI C
STEIN DS
MARKOWITZ N
REVES R
LOVELESS MO
CRANE L
THOMPSON M
ABRAMS D
Citation: Ld. Saravolatz et al., ZIDOVUDINE ALONE OR IN COMBINATION WITH DIDANOSINE OR ZALCITABINE IN HIV-INFECTED PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME OR FEWER THAN 200 CD4 CELLS PER CUBIC MILLIMETER, The New England journal of medicine, 335(15), 1996, pp. 1099-1106
Authors:
BILELLO JA
STELLRECHT K
DRUSANO GL
STEIN DS
Citation: Ja. Bilello et al., SOLUBLE TUMOR-NECROSIS-FACTOR-ALPHA RECEPTOR-TYPE-II (STNF-ALPHA-RII)CORRELATES WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) RNA COPY NUMBER INHIV-INFECTED PATIENTS, The Journal of infectious diseases, 173(2), 1996, pp. 464-467
Authors:
STEIN DS
GRAHAM NMH
PARK LP
HOOVER DR
SAAH AJ
Citation: Ds. Stein et al., ACYCLOVIR IN HUMAN-IMMUNODEFICIENCY-VIRUS PATIENTS, The Journal of infectious diseases, 173(2), 1996, pp. 504-505
Authors:
CHEESEMAN SH
HAVLIR D
MCLAUGHLIN MM
GREENOUGH TC
SULLIVAN JL
HALL D
HATTOX SE
SPECTOR SA
STEIN DS
MYERS M
RICHMAN DD
Citation: Sh. Cheeseman et al., PHASE I II EVALUATION OF NEVIRAPINE ALONE AND IN COMBINATION WITH ZIDOVUDINE FOR INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS/, Journal of acquired immune deficiency syndromes and human retrovirology, 8(2), 1995, pp. 141-151
Authors:
STEIN DS
STEVENS RC
Citation: Ds. Stein et Rc. Stevens, TREATMENT-ASSOCIATED TOXICITIES - INCIDENCE AND MECHANISMS, Bailliere's clinical infectious diseases, 2(3), 1995, pp. 505-530
Authors:
STEIN DS
GOLTZ J
Citation: Ds. Stein et J. Goltz, REL-HOMOLOGOUS PROTEINS IN DROSOPHILA - THE DORSAL-RELATED IMMUNITY FACTOR (DIF) CAN DEFINE THE DORSAL-VENTRAL AXIS OF POLARITY IN THE EMBRYO, Journal of cellular biochemistry, 1995, pp. 212-212
Authors:
VOLBERDING PA
LAGAKOS SW
GRIMES JM
STEIN DS
ROONEY J
MENG TC
FISCHL MA
COLLIER AC
PHAIR JP
HIRSCH MS
HARDY WD
BALFOUR HH
REICHMAN RC
Citation: Pa. Volberding et al., A COMPARISON OF IMMEDIATE WITH DEFERRED ZIDOVUDINE THERAPY FOR ASYMPTOMATIC HIV-INFECTED ADULTS WITH CD4 CELL COUNTS OF 500 OR MORE PER CUBIC MILLIMETER, The New England journal of medicine, 333(7), 1995, pp. 401-407